Due to health issues, this site is no longer maintained and will be shut down shortly.

IT:BLRX BioLineRx Ltd.

BioLine Rx Ltd is a clinical stage biopharmaceutical development company engaged in identifying, in-licensing & developing therapeutic compounds.This company has ADRs that trade in the U.S. as the symbol BLRX.

17.50 ILS
As of 03/22/2023


Security Information
Category1:  Global Equity
Category2:  Common stocks
Category3:  Developed markets ex-US
GICS sector:  Health Care
Industry:  
Index country:  Israel
Country of incorporation:  Israel
IPO date:  01/01/1900
Stock exchange:    Tel Aviv Stock Exchange
Exchange country:   Israel
Market cap:   0 ILS
Current dividend yield:   0.00%
Sedol:      

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy